Patients are placed at the forefront of research and are empowered to actively participate in the development of new treatments and therapies. The CRF’s innovative clinical trials have the potential to develop new treatments and therapies that could improve and save lives.
The CRF’s research is focused on addressing some of the biggest killers in the world: cardiovascular and respiratory diseases. In the UK, one in every four deaths is caused by cardiovascular disease and 20% of deaths by respiratory disease.
Despite a growing awareness of risk factors, such as smoking and poor diet, the prevalence of such diseases is increasing. The work is vital in developing new approaches to diagnosing and treating heart and lung disease, and new medicines.
By supporting the CRF, donors and supporters can play a vital role in advancing heart and lung research.
Donations go directly towards funding critical research and resources for patients participating in clinical trials. With continued support, the CRF has the potential to develop new treatments and therapies that could transform the lives of millions of people affected by heart and lung disease.